FTDI
CLB icon

First Trust Direct Indexing’s Core Laboratories CLB Stock Holding History

First Trust Direct Indexing’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,607
Closed -$96K – 505
2020
Q4 		$96K Buy
+3,607
New +$73.7K 0.03% 521

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Direct Indexing's CLB Position: Q1 2021 in Review

First Trust Direct Indexing sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 3,607 shares — an estimated $96K sold.

First Trust Direct Indexing first reported a position in CLB in Q4 2020 and held it in 1 quarter. The position peaked at $96K in Q4 2020. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • First Trust Direct Indexing reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 3,607 Core Laboratories shares in Q1 2021, an estimated $96K.
  • First Trust Direct Indexing first reported a position in Core Laboratories in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's Core Laboratories position peaked at $96K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.